Year |
Citation |
Score |
2013 |
Guillemin R. A conversation with Roger Guillemin. Interview by Greg Lemke. Annual Review of Physiology. 75: 1-22. PMID 23398151 DOI: 10.1146/annurev-physiol-082712-104641 |
0.362 |
|
2011 |
Guillemin R. Neuroendocrinology: a short historical review. Annals of the New York Academy of Sciences. 1220: 1-5. PMID 21388398 DOI: 10.1111/j.1749-6632.2010.05936.x |
0.401 |
|
2008 |
Guillemin R, Perrin MH. Neuroendocrinology: past, present and future. Annales D'Endocrinologie. 69: 160. PMID 18407243 DOI: 10.1016/j.ando.2008.02.018 |
0.321 |
|
2008 |
Guillemin R. Somatostatin: the beginnings, 1972. Molecular and Cellular Endocrinology. 286: 3-4. PMID 18395969 DOI: 10.1016/j.mce.2008.02.025 |
0.478 |
|
2005 |
Guillemin R. Hypothalamic hormones a.k.a. hypothalamic releasing factors. The Journal of Endocrinology. 184: 11-28. PMID 15642779 DOI: 10.1677/joe.1.05883 |
0.446 |
|
2003 |
GUILLEMIN R, HEARN WR. ACTH release by in vitro pituitary; effect of pitressin and purified arginine-vasopressin. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 89: 365-7. PMID 13254762 DOI: 10.3181/00379727-89-21812 |
0.312 |
|
1998 |
WARD DN, WALBORG EF, LIPSCOMB HS, GUILLEMIN R. Fractionation and analysis of monkey pituitary glands for posterior lobe hormones. Acta Endocrinologica. 40: 283-9. PMID 14004927 DOI: 10.1530/acta.0.0400283 |
0.365 |
|
1996 |
GUILLEMIN R. HYPOTHALAMIC POLYPEPTIDES RELEASING PITUITARY HORMONES. Metabolism: Clinical and Experimental. 13: SUPPL:1206-10. PMID 14228767 DOI: 10.1016/S0026-0495(64)80037-8 |
0.431 |
|
1993 |
Guillemin R. Somatostatin: the early days. Digestion. 54: 3-6. PMID 8103012 DOI: 10.1159/000201066 |
0.376 |
|
1989 |
Cuevas P, Carceller F, Esteban A, Baird A, Guillemin R. Basic fibroblast growth factor (bFGF) enhances retinal ganglion cells’ survival and promotes axonal growth of rat transected optic nerve Acta Neurologica Scandinavica. 79: 263-263. DOI: 10.1111/J.1600-0404.1989.Tb03770.X |
0.43 |
|
1988 |
Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ling N, Guillemin R. Primary structure of the human follistatin precursor and its genomic organization. Proceedings of the National Academy of Sciences of the United States of America. 85: 4218-22. PMID 3380788 DOI: 10.1073/Pnas.85.12.4218 |
0.303 |
|
1988 |
Ling N, Ueno N, Ying SY, Esch F, Shimasaki S, Hotta M, Cuevas P, Guillemin R. Inhibins and activins. Vitamins and Hormones. 44: 1-46. PMID 3070928 DOI: 10.1016/S0083-6729(08)60692-5 |
0.395 |
|
1988 |
Baird A, Schubert D, Ling N, Guillemin R. Receptor- and heparin-binding domains of basic fibroblast growth factor. Proceedings of the National Academy of Sciences of the United States of America. 85: 2324-8. PMID 2832850 DOI: 10.1073/Pnas.85.7.2324 |
0.491 |
|
1987 |
Ueno N, Baird A, Esch F, Ling N, Guillemin R. Isolation and partial characterization of basic fibroblast growth factor from bovine testis. Molecular and Cellular Endocrinology. 49: 189-94. PMID 3556754 DOI: 10.1016/0303-7207(87)90212-7 |
0.49 |
|
1987 |
Cuevas P, Ying SY, Ling N, Ueno N, Esch F, Guillemin R, Healy D, Ta S. Immunohistochemical detection of inhibin in the gonad. Biochemical and Biophysical Research Communications. 142: 23-30. PMID 3545204 DOI: 10.1016/0006-291X(87)90446-3 |
0.338 |
|
1987 |
Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S, Ueno N, Guillemin R. Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Molecular Endocrinology (Baltimore, Md.). 1: 849-55. PMID 3153465 DOI: 10.1210/mend-1-11-849 |
0.325 |
|
1987 |
Ying SY, Becker A, Swanson G, Tan P, Ling N, Esch F, Ueno N, Shimasaki S, Guillemin R. Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro. Biochemical and Biophysical Research Communications. 149: 133-9. PMID 3120723 DOI: 10.1016/0006-291X(87)91614-7 |
0.451 |
|
1987 |
Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proceedings of the National Academy of Sciences of the United States of America. 84: 8282-6. PMID 3120188 DOI: 10.1073/Pnas.84.23.8282 |
0.403 |
|
1987 |
Ying SY, Czvik J, Becker A, Ling N, Ueno N, Guillemin R. Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related. Proceedings of the National Academy of Sciences of the United States of America. 84: 4631-5. PMID 3110772 DOI: 10.1073/pnas.84.13.4631 |
0.383 |
|
1987 |
Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin Obstetrical and Gynecological Survey. 42: 109-111. DOI: 10.1097/00006254-198702000-00015 |
0.369 |
|
1986 |
Ueno N, Baird A, Esch F, Shimasaki S, Ling N, Guillemin R. Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor. Regulatory Peptides. 16: 135-45. PMID 3809608 DOI: 10.1016/0167-0115(86)90057-1 |
0.5 |
|
1986 |
Ueno N, Baird A, Esch F, Ling N, Guillemin R. Isolation of an amino terminal extended form of basic fibroblast growth factor. Biochemical and Biophysical Research Communications. 138: 580-8. PMID 3741423 DOI: 10.1016/S0006-291X(86)80536-8 |
0.477 |
|
1986 |
Baird A, Esch F, Mormède P, Ueno N, Ling N, Böhlen P, Ying SY, Wehrenberg WB, Guillemin R. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Progress in Hormone Research. 42: 143-205. PMID 3526451 DOI: 10.1016/B978-0-12-571142-5.50008-2 |
0.481 |
|
1986 |
Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proceedings of the National Academy of Sciences of the United States of America. 83: 3012-6. PMID 3458259 DOI: 10.1073/Pnas.83.9.3012 |
0.441 |
|
1986 |
Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochemical and Biophysical Research Communications. 138: 1129-37. PMID 3092817 DOI: 10.1016/S0006-291X(86)80400-4 |
0.408 |
|
1986 |
Ying SY, Becker A, Ling N, Ueno N, Guillemin R. Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochemical and Biophysical Research Communications. 136: 969-75. PMID 3087350 DOI: 10.1016/0006-291X(86)90427-4 |
0.384 |
|
1986 |
Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature. 321: 779-82. PMID 3086749 DOI: 10.1038/321779a0 |
0.415 |
|
1986 |
Ying SY, Becker A, Baird A, Ling N, Ueno N, Esch F, Guillemin R. Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. Biochemical and Biophysical Research Communications. 135: 950-6. PMID 3083816 DOI: 10.1016/0006-291X(86)91020-X |
0.545 |
|
1986 |
Bloch B, Baird A, Ling N, Guillemin R. Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor. Endocrinology. 118: 156-62. PMID 3079700 DOI: 10.1210/Endo-118-1-156 |
0.519 |
|
1986 |
Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proceedings of the National Academy of Sciences of the United States of America. 83: 7297-301. PMID 2429303 DOI: 10.1073/Pnas.83.19.7297 |
0.448 |
|
1985 |
Esch F, Ueno N, Baird A, Hill F, Denoroy L, Ling N, Gospodarowicz D, Guillemin R. Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochemical and Biophysical Research Communications. 133: 554-62. PMID 4084288 DOI: 10.1016/0006-291X(85)90942-8 |
0.477 |
|
1985 |
Baird A, Böhlen P, Ling N, Guillemin R. Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro. Regulatory Peptides. 10: 309-17. PMID 4039829 DOI: 10.1016/0167-0115(85)90043-6 |
0.543 |
|
1985 |
Baird A, Mormède P, Ying SY, Wehrenberg WB, Ueno N, Ling N, Guillemin R. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proceedings of the National Academy of Sciences of the United States of America. 82: 5545-9. PMID 3927303 DOI: 10.1073/Pnas.82.16.5545 |
0.567 |
|
1985 |
Baird A, Esch F, Gospodarowicz D, Guillemin R. Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry. 24: 7855-60. PMID 3912009 DOI: 10.1021/Bi00348A001 |
0.474 |
|
1985 |
Ling N, Ying SY, Ueno N, Esch F, Denoroy L, Guillemin R. Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proceedings of the National Academy of Sciences of the United States of America. 82: 7217-21. PMID 3864157 DOI: 10.1073/pnas.82.21.7217 |
0.322 |
|
1985 |
Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Böhlen P, Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proceedings of the National Academy of Sciences of the United States of America. 82: 6507-11. PMID 3863109 DOI: 10.1073/Pnas.82.19.6507 |
0.484 |
|
1985 |
Ling N, Zeytin F, Böhlen P, Esch F, Brazeau P, Wehrenberg WB, Baird A, Guillemin R. Growth hormone releasing factors. Annual Review of Biochemistry. 54: 403-23. PMID 2992358 DOI: 10.1146/Annurev.Bi.54.070185.002155 |
0.528 |
|
1985 |
Benoit R, Bohlen P, Ling N, Esch F, Baird A, Ying SY, Wehrenberg WB, Guillemin R, Morrison JH, Bakhit C. Somatostatin-28 [1-12]-like peptides. Advances in Experimental Medicine and Biology. 188: 89-107. PMID 2863951 DOI: 10.1007/978-1-4615-7886-4_6 |
0.525 |
|
1985 |
Wehrenberg WB, Baird A, Zeytin F, Esch F, Böhlen P, Ling N, Ying SY, Guillemin R. Physiological studies with somatocrinin, a growth hormone-releasing factor. Annual Review of Pharmacology and Toxicology. 25: 463-83. PMID 2860847 DOI: 10.1146/annurev.pa.25.040185.002335 |
0.485 |
|
1985 |
Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H, Seeburg PH. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature. 318: 659-63. PMID 2417121 DOI: 10.1038/318659a0 |
0.373 |
|
1985 |
Baird A, Culler F, Jones KL, Guillemin R. Angiogenic factor in human ocular fluid. Lancet (London, England). 2: 563. PMID 2412079 DOI: 10.1016/S0140-6736(85)90512-4 |
0.41 |
|
1984 |
Böhlen P, Wehrenberg WB, Esch F, Ling N, Brazeau P, Guillemin R. Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis. Biochemical and Biophysical Research Communications. 125: 1005-12. PMID 6440563 DOI: 10.1016/0006-291X(84)91383-4 |
0.384 |
|
1984 |
Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB, Guillemin R. Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis. Biochemical and Biophysical Research Communications. 125: 606-14. PMID 6440561 DOI: 10.1016/0006-291X(84)90582-5 |
0.402 |
|
1984 |
Ling N, Esch F, Böhlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proceedings of the National Academy of Sciences of the United States of America. 81: 4302-6. PMID 6431406 DOI: 10.1073/Pnas.81.14.4302 |
0.398 |
|
1984 |
Bloch B, Ling N, Benoit R, Wehrenberg WB, Guillemin R. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature. 307: 272-3. PMID 6420704 DOI: 10.1038/307272a0 |
0.382 |
|
1984 |
Esch F, Ling N, Bohlen P, Baird A, Benoit R, Guillemin R. Isolation and characterization of the bovine hypothalamic corticotropin-releasing factor. Biochemical and Biophysical Research Communications. 122: 899-905. PMID 6332625 DOI: 10.1016/0006-291X(84)91175-6 |
0.48 |
|
1984 |
Ling N, Esch F, Böhlen P, Baird A, Guillemin R. Isolation and characterization of caprine corticotropin-releasing factor. Biochemical and Biophysical Research Communications. 122: 1218-24. PMID 6332624 DOI: 10.1016/0006-291X(84)91222-1 |
0.482 |
|
1984 |
Wehrenberg WB, Baird A, Ying SY, Rivier C, Ling N, Guillemin R. Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors. Endocrinology. 114: 1995-2001. PMID 6327231 DOI: 10.1210/Endo-114-6-1995 |
0.664 |
|
1984 |
Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB, Bloch B, Mougin C, Zeytin F, Baird A. Somatocrinin, the growth hormone releasing factor. Recent Progress in Hormone Research. 40: 233-99. PMID 6148773 DOI: 10.1016/B978-0-12-571140-1.50011-6 |
0.49 |
|
1984 |
Wehrenberg WB, Bloch B, Chong-Li Z, Brazeau P, Ling N, Guillemin R. Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion. Regulatory Peptides. 8: 1-8. PMID 6144144 DOI: 10.1016/0167-0115(84)90023-5 |
0.355 |
|
1984 |
Wehrenberg WB, Brazeau P, Ling N, Textor G, Guillemin R. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. Endocrinology. 114: 1613-6. PMID 6143658 DOI: 10.1210/endo-114-5-1613 |
0.372 |
|
1983 |
Esch F, Böhlen P, Ling N, Brazeau P, Guillemin R. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochemical and Biophysical Research Communications. 117: 772-9. PMID 6421287 DOI: 10.1016/0006-291X(83)91664-9 |
0.416 |
|
1983 |
Böhlen P, Esch F, Brazeau P, Ling N, Guillemin R. Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochemical and Biophysical Research Communications. 116: 726-34. PMID 6418166 DOI: 10.1016/0006-291X(83)90585-5 |
0.413 |
|
1983 |
Böhlen P, Brazeau P, Bloch B, Ling N, Gaillard R, Guillemin R. Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochemical and Biophysical Research Communications. 114: 930-6. PMID 6412708 DOI: 10.1016/0006-291X(83)90649-6 |
0.392 |
|
1983 |
Wehrenberg WB, Benoit R, Baird A, Guillemin R. Inhibitory effects of cysteamine on neuroendocrine function. Regulatory Peptides. 6: 137-45. PMID 6410461 DOI: 10.1016/0167-0115(83)90006-X |
0.559 |
|
1983 |
Rosenthal SM, Schriock EA, Kaplan SL, Guillemin R, Grumbach MM. Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men. The Journal of Clinical Endocrinology and Metabolism. 57: 677-9. PMID 6409919 DOI: 10.1210/jcem-57-3-677 |
0.414 |
|
1983 |
Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, Benoit R, Bloom F, Guillemin R. Immunohistochemical detection of growth hormone-releasing factor in brain. Nature. 301: 607-8. PMID 6402707 DOI: 10.1038/301607a0 |
0.604 |
|
1983 |
Bloch B, Baird A, Ling N, Benoit R, Guillemin R. Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin. Brain Research. 263: 251-7. PMID 6340794 DOI: 10.1016/0006-8993(83)90317-7 |
0.482 |
|
1983 |
Böhlen P, Brazeau P, Esch F, Ling N, Wehrenberg WB, Guillemin R. Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization. Regulatory Peptides. 6: 343-53. PMID 6138818 DOI: 10.1016/0167-0115(83)90263-X |
0.427 |
|
1983 |
Wehrenberg WB, Brazeau P, Luben R, Ling N, Guillemin R. A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor. Neuroendocrinology. 36: 489-91. PMID 6136006 DOI: 10.1159/000123504 |
0.442 |
|
1983 |
Antoni FA, Palkovits M, Makara GB, Linton EA, Lowry PJ, Kiss JZ, Bugajski J, Gą A, dek, Walker RF, Luine VN, McEwen BS, Wehrenberg WB, Brazeau P, Luben R, ... ... Guillemin R, et al. Subject Index Vol. 36, 1983 Neuroendocrinology. 36: 495-496. DOI: 10.1159/000123507 |
0.344 |
|
1983 |
Antoni FA, Palkovits M, Makara GB, Linton EA, Lowry PJ, Kiss JZ, Bugajski J, Gą A, dek, Walker RF, Luine VN, McEwen BS, Wehrenberg WB, Brazeau P, Luben R, ... ... Guillemin R, et al. Contents, Vol. 36, 1983 Neuroendocrinology. 36. DOI: 10.1159/000123490 |
0.365 |
|
1982 |
Esch FS, Böhlen P, Ling NC, Brazeau PE, Wehrenberg WB, Thorner MO, Cronin MJ, Guillemin R. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochemical and Biophysical Research Communications. 109: 152-8. PMID 7159418 DOI: 10.1016/0006-291X(82)91578-9 |
0.393 |
|
1982 |
Benoit R, Ling N, Bakhit C, Morrison JH, Alford B, Guillemin R. Somatostatin-28(1-12)-like immunoreactivity in the rat. Endocrinology. 111: 2149-51. PMID 7140652 DOI: 10.1210/endo-111-6-2149 |
0.341 |
|
1982 |
Baird A, Ling N, Böhlen P, Benoit R, Klepper R, Guillemin R. Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus. Proceedings of the National Academy of Sciences of the United States of America. 79: 2023-5. PMID 6952250 DOI: 10.1073/Pnas.79.6.2023 |
0.469 |
|
1982 |
Wehrenberg WB, Ling N, Brazeau P, Esch F, Böhlen P, Baird A, Ying S, Guillemin R. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochemical and Biophysical Research Communications. 109: 382-7. PMID 6817757 DOI: 10.1016/0006-291X(82)91732-6 |
0.588 |
|
1982 |
Luben RA, Brazeau P, Böhlen P, Guillemin R. Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen. Science (New York, N.Y.). 218: 887-9. PMID 6813967 DOI: 10.1126/Science.6813967 |
0.37 |
|
1982 |
Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science (New York, N.Y.). 218: 585-7. PMID 6812220 DOI: 10.1126/science.6812220 |
0.421 |
|
1982 |
Brazeau P, Ling N, Esch F, Böhlen P, Mougin C, Guillemin R. Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. Biochemical and Biophysical Research Communications. 109: 588-94. PMID 6185122 DOI: 10.1016/0006-291X(82)91762-4 |
0.416 |
|
1982 |
Brazeau P, Ling N, Böhlen P, Esch F, Ying SY, Guillemin R. Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proceedings of the National Academy of Sciences of the United States of America. 79: 7909-13. PMID 6130528 DOI: 10.1073/pnas.79.24.7909 |
0.442 |
|
1982 |
Wehrenberg WB, Ling N, Böhlen P, Esch F, Brazeau P, Guillemin R. Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochemical and Biophysical Research Communications. 109: 562-7. PMID 6129852 DOI: 10.1016/0006-291X(82)91758-2 |
0.396 |
|
1982 |
Wehrenberg WB, Brazeau P, Luben R, Böhlen P, Guillemin R. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology. 111: 2147-8. PMID 6128220 DOI: 10.1210/Endo-111-6-2147 |
0.413 |
|
1982 |
Benoit R, Ling N, Alford B, Guillemin R. Seven peptides derived from pro-somatostatin in rat brain. Biochemical and Biophysical Research Communications. 107: 944-50. PMID 6127997 DOI: 10.1016/0006-291X(82)90614-3 |
0.379 |
|
1982 |
Benoit R, Böhlen P, Ling N, Briskin A, Esch F, Brazeau P, Ying SY, Guillemin R. Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proceedings of the National Academy of Sciences of the United States of America. 79: 917-21. PMID 6121326 DOI: 10.1073/Pnas.79.3.917 |
0.359 |
|
1981 |
Böhlen P, Esch F, Shibasaki T, Baird A, Ling N, Guillemin R. Isolation and characterization of a gamma 1-melanotropin-like peptide from bovine neurointermediate pituitary. Febs Letters. 128: 67-70. PMID 7274457 DOI: 10.1016/0014-5793(81)81081-2 |
0.514 |
|
1981 |
Shibasaki T, Ling N, Guillemin R, Silver M, Bloom F. The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin. Regulatory Peptides. 2: 43-52. PMID 6262881 DOI: 10.1016/0167-0115(81)90064-1 |
0.526 |
|
1981 |
Shibasaki T, Masui H, Sato G, Ling N, Guillemin R. Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease. The Journal of Clinical Endocrinology and Metabolism. 52: 350-3. PMID 6257745 DOI: 10.1210/jcem-52-2-350 |
0.372 |
|
1981 |
Ying SY, Ling N, Böhlen P, Guillemin R. Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. Endocrinology. 108: 1206-15. PMID 6162633 DOI: 10.1210/endo-108-4-1206 |
0.429 |
|
1981 |
Böhlen P, Brazeau P, Esch F, Ling N, Guillemin R. Isolation and chemical characterization of somatostatin-28 from rat hypothalamus. Regulatory Peptides. 2: 359-69. PMID 6117931 DOI: 10.1016/0167-0115(81)90018-5 |
0.361 |
|
1981 |
Brazeau P, Ling N, Esch F, Böhlen P, Benoit R, Guillemin R. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regulatory Peptides. 1: 255-64. PMID 6114516 DOI: 10.1016/0167-0115(81)90048-3 |
0.413 |
|
1981 |
Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 291: 76-7. PMID 6112710 DOI: 10.1038/291076A0 |
0.437 |
|
1980 |
Shibasaki T, Ling N, Guillemin R. A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus. Biochemical and Biophysical Research Communications. 96: 1393-9. PMID 7437077 DOI: 10.1016/0006-291X(80)90105-9 |
0.326 |
|
1980 |
Jackson IM, Bolaffi JL, Guillemin R. Presence of immunoreactive beta-endorphin and enkephalin-like material in the retina and other tissues of the frog, Rana pipiens. General and Comparative Endocrinology. 42: 505-8. PMID 6970153 DOI: 10.1016/0016-6480(80)90217-8 |
0.323 |
|
1980 |
Bloom FE, Battenberg EL, Shibasaki T, Benoit R, Ling N, Guillemin R. Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary. Regulatory Peptides. 1: 205-22. PMID 6262877 DOI: 10.1016/0167-0115(80)90272-4 |
0.54 |
|
1980 |
Rossier J, French E, Guillemin R, Bloom FE. On the mechanisms of the simultaneous release of immunoreactive beta-endorphin, ACTH, and prolactin by stress. Advances in Biochemical Psychopharmacology. 22: 363-75. PMID 6249081 |
0.504 |
|
1980 |
Shibasaki T, Ling N, Guillemin R. A radioimmunoassay for gamma-melanocyte stimulating hormone. Life Sciences. 26: 1781-5. PMID 6248714 DOI: 10.1016/0024-3205(80)90578-0 |
0.34 |
|
1980 |
Rossier J, French E, Rivier C, Shibasaki T, Guillemin R, Bloom FE. Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation. Proceedings of the National Academy of Sciences of the United States of America. 77: 666-9. PMID 6244573 DOI: 10.1073/Pnas.77.1.666 |
0.715 |
|
1980 |
Esch F, Böhlen P, Ling N, Benoit R, Brazeau P, Guillemin R. Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proceedings of the National Academy of Sciences of the United States of America. 77: 6827-31. PMID 6109284 DOI: 10.1073/Pnas.77.11.6827 |
0.345 |
|
1980 |
Benoit R, Böhlen P, Brazeau P, Ling N, Guillemin R. Isolation and characterization of rat pancreatic somatostatin. Endocrinology. 107: 2127-9. PMID 6107246 DOI: 10.1210/endo-107-6-2127 |
0.346 |
|
1980 |
Böhlen P, Brazeau P, Benoit R, Ling N, Esch F, Guillemin R. Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25. Biochemical and Biophysical Research Communications. 96: 725-34. PMID 6107078 DOI: 10.1016/0006-291X(80)91415-1 |
0.337 |
|
1980 |
Ling N, Esch F, Davis D, Mercado M, Regno M, Bohlen P, Brazeau P, Guillemin R. Solid phase synthesis of somatostatin-28. Biochemical and Biophysical Research Communications. 95: 945-51. PMID 6106480 DOI: 10.1016/0006-291X(80)91564-8 |
0.324 |
|
1980 |
Rossier J, Pittman Q, Bloom F, Guillemin R. Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway. Federation Proceedings. 39: 2555-60. PMID 6103825 |
0.486 |
|
1980 |
Shibasaki T, Ling N, Guillemin R. Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides. Nature. 285: 416-7. PMID 6101229 DOI: 10.1038/285416A0 |
0.386 |
|
1979 |
Rossier J, French E, Gros C, Minick S, Guillemin R, Bloom FE. Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain. Life Sciences. 25: 2105-12. PMID 537470 DOI: 10.1016/0024-3205(79)90204-2 |
0.627 |
|
1979 |
Lavielle S, Ling N, Brazeau P, Benoit R, Wasada T, Harris D, Unger R, Guillemin R. Synthesis and biological activity of glycosylated analogs of somatostatin. Biochemical and Biophysical Research Communications. 91: 614-22. PMID 518658 DOI: 10.1016/0006-291X(79)91566-3 |
0.368 |
|
1979 |
Bayon A, Shoemaker WJ, Bloom FE, Mauss A, Guillemin R. Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain. Brain Research. 179: 93-101. PMID 509236 DOI: 10.1016/0006-8993(79)90493-1 |
0.485 |
|
1979 |
Chorev M, Shavitz R, Goodman M, Minick S, Guillemin R. Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo. Science (New York, N.Y.). 204: 1210-2. PMID 451565 DOI: 10.1126/Science.451565 |
0.305 |
|
1979 |
Ying SY, Guillemin R. Dried Staphylococcus aureus as a rapid immunological separating agent in radioimmunoassays. The Journal of Clinical Endocrinology and Metabolism. 48: 360-2. PMID 429490 DOI: 10.1210/jcem-48-2-360 |
0.307 |
|
1979 |
Rossier J, Rogers J, Shibasaki T, Guillemin R, Bloom FE. Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development. Proceedings of the National Academy of Sciences of the United States of America. 76: 2077-80. PMID 287046 DOI: 10.1073/Pnas.76.4.2077 |
0.588 |
|
1979 |
Ling N, Ying S, Minick S, Guillemin R. Synthesis and biological activity of four gamma-melanotropin peptides derived from the cryuptic region of the adrenocorticotropin/beta-lipotropin precursor. Life Sciences. 25: 1773-9. PMID 231164 DOI: 10.1016/0024-3205(79)90481-8 |
0.366 |
|
1979 |
Shibasaki T, Deftos L, Guillemin R. Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma. Biochemical and Biophysical Research Communications. 90: 1266-73. PMID 229834 DOI: 10.1016/0006-291X(79)91173-2 |
0.332 |
|
1979 |
Ying SY, Guillemin R. DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats. Nature. 280: 593-5. PMID 223068 DOI: 10.1038/280593A0 |
0.441 |
|
1979 |
Ying SY, Guillemin R. [Gonadostatin and gonadocrinin, polypeptides of ovarian origin with hypophysiotropic activity]. Comptes Rendus Des SéAnces De L'AcadéMie Des Sciences. SéRie D, Sciences Naturelles. 289: 943-6. PMID 121254 |
0.327 |
|
1979 |
Hosobuchi Y, Rossier J, Bloom FE, Guillemin R. Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid. Science (New York, N.Y.). 203: 279-81. PMID 83674 DOI: 10.1126/Science.83674 |
0.615 |
|
1979 |
Rossier J, Battenberg E, Pittman Q, Bayon A, Koda L, Miller R, Guillemin R, Bloom F. Hypothalamic enkephalin neurones may regulate the neurohypophysis. Nature. 277: 653-5. PMID 34105 DOI: 10.1038/277653A0 |
0.616 |
|
1979 |
Bloom FE, Rossier J, Battenberg ELF, Bayon A, French ED, Henriksen SJ, Siggins GR, Ling N, Guillemin R. β-Endorphin: cellular localization, electrophysiological and behavioral effects Advances in Biochemical Psychopharmacology. 18: 17-29. DOI: 10.1007/978-1-349-04015-5_2 |
0.56 |
|
1978 |
Rossier J, Guillemin R, Bloom F. Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus. European Journal of Pharmacology. 48: 465-6. PMID 565718 DOI: 10.1016/0014-2999(78)90178-4 |
0.582 |
|
1978 |
Deftos LJ, Burton D, Catherwood BD, Bone HG, Parthemore JG, Guillemin R, Watkins WB, Moore RY. Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary. The Journal of Clinical Endocrinology and Metabolism. 47: 457-60. PMID 400721 DOI: 10.1210/jcem-47-2-457 |
0.34 |
|
1978 |
Bloom F, Battenberg E, Rossier J, Ling N, Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proceedings of the National Academy of Sciences of the United States of America. 75: 1591-5. PMID 349568 DOI: 10.1073/Pnas.75.3.1591 |
0.623 |
|
1978 |
Henriksen SJ, Bloom FE, McCoy F, Ling N, Guillemin R. beta-Endorphin induces nonconvulsive limbic seizures. Proceedings of the National Academy of Sciences of the United States of America. 75: 5221-5. PMID 283426 DOI: 10.1073/pnas.75.10.5221 |
0.507 |
|
1978 |
Bayon A, Rossier J, Mauss A, Bloom FE, Iversen LL, Ling N, Guillemin R. In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus. Proceedings of the National Academy of Sciences of the United States of America. 75: 3503-6. PMID 277953 DOI: 10.1073/Pnas.75.7.3503 |
0.642 |
|
1978 |
Orth DN, Guillemin R, Ling N, Nicholson WE. Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. The Journal of Clinical Endocrinology and Metabolism. 46: 849-52. PMID 233636 DOI: 10.1210/jcem-46-5-849 |
0.32 |
|
1978 |
Vale W, Rivier C, Yang L, Minick S, Guillemin R. Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro. Endocrinology. 103: 1910-5. PMID 218793 DOI: 10.1210/endo-103-5-1910 |
0.652 |
|
1978 |
Bloom FE, Rossier J, Battenberg EL, Bayon A, French E, Henriksen SJ, Siggins GR, Segal D, Browne R, Ling N, Guillemin R. beta-endorphin: cellular localization, electrophysiological and behavioral effects. Advances in Biochemical Psychopharmacology. 18: 89-109. PMID 77124 |
0.411 |
|
1978 |
Guillemin R. Beta-lipotropin and endorphins: implications of current knowledge. Hospital Practice. 13: 53-60. PMID 33114 DOI: 10.1080/21548331.1978.11707431 |
0.392 |
|
1978 |
Iversen LL, Iversen SD, Bloom FE, Vargo T, Guillemin R. Release of enkephalin from rat globus pallidus in vitro. Nature. 271: 679-81. PMID 24182 DOI: 10.1038/271679A0 |
0.535 |
|
1978 |
Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. β-ENDORPHIN AND ADRENOCORTICOTROPIN ARE SECRETED CONCOMITANTLY BY THE PITUITARY GLAND Obstetrical & Gynecological Survey. 33: 184-185. DOI: 10.1097/00006254-197803000-00017 |
0.714 |
|
1977 |
Rossier J, Bayon A, Vargo TM, Ling N, Guillemin R, Bloom F. Radioimmunoassay of brain peptides: evaluation of a methodology for the assay of beta-endorphin and enkephalin. Life Sciences. 21: 847-52. PMID 916802 DOI: 10.1016/0024-3205(77)90414-3 |
0.608 |
|
1977 |
Segal DS, Browne RG, Bloom F, Ling N, Guillemin R. beta-Endorphin: endogenous opiate or neuroleptic? Science (New York, N.Y.). 198: 411-4. PMID 910136 DOI: 10.1126/science.910136 |
0.509 |
|
1977 |
Guillemin R, Ling N, Burgus R, Bloom F, Segal D. Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes. Psychoneuroendocrinology. 2: 59-62. PMID 905475 DOI: 10.1016/0306-4530(77)90032-4 |
0.507 |
|
1977 |
Janowsky DS, Segal DS, Bloom F, Abrams A, Guillemin R. Lack of effect on naloxone on schizophrenic symptoms. The American Journal of Psychiatry. 134: 926-7. PMID 879360 DOI: 10.1176/ajp.134.8.926 |
0.317 |
|
1977 |
Guillemin R. Purification, isolation, and primary structure of the hypothalamic luteinizing hormone-releasing factor of ovine origin. A historical account. American Journal of Obstetrics and Gynecology. 129: 214-8. PMID 331955 DOI: 10.1016/0002-9378(77)90749-9 |
0.414 |
|
1977 |
Bloom F, Battenberg E, Rossier J, Ling N, Leppaluoto J, Vargo TM, Guillemin R. Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. Life Sciences. 20: 43-7. PMID 319317 DOI: 10.1016/0024-3205(77)90126-6 |
0.624 |
|
1977 |
Guillemin R, Ling N, Lazarus L, Burgus R, Minick S, Bloom F, Nicoll R, Siggins G, Segal D. The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: biochemical and biologic studies. Annals of the New York Academy of Sciences. 297: 131-57. PMID 279259 DOI: 10.1111/J.1749-6632.1977.Tb41850.X |
0.495 |
|
1977 |
Rossier J, Vargo TM, Minick S, Ling N, Bloom FE, Guillemin R. Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. Proceedings of the National Academy of Sciences of the United States of America. 74: 5162-5. PMID 270754 DOI: 10.1073/Pnas.74.11.5162 |
0.625 |
|
1977 |
Nicoll RA, Siggins GR, Ling N, Bloom FE, Guillemin R. Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. Proceedings of the National Academy of Sciences of the United States of America. 74: 2584-8. PMID 267951 DOI: 10.1073/Pnas.74.6.2584 |
0.515 |
|
1977 |
Rossier J, French ED, Rivier C, Ling N, Guillemin R, Bloom FE. Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature. 270: 618-20. PMID 201864 DOI: 10.1038/270618A0 |
0.666 |
|
1977 |
Kan KW, Baird A, Seidah NG, Lis M, Chrétien M, Ling N, Guillemin R, Solomon S. Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture. Biochemical and Biophysical Research Communications. 79: 553-60. PMID 201254 DOI: 10.1016/0006-291X(77)90193-0 |
0.459 |
|
1977 |
Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science (New York, N.Y.). 197: 1367-9. PMID 197601 DOI: 10.1126/Science.197601 |
0.747 |
|
1977 |
Rivier C, Vale W, Ling N, Brown M, Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 100: 238-41. PMID 187406 DOI: 10.1210/endo-100-1-238 |
0.645 |
|
1977 |
Guillemin R. The endocrinology of the neuron and the neural origin of endocrine cells. Advances in Experimental Medicine and Biology. 87: 1-12. PMID 19951 DOI: 10.1007/978-1-4615-8849-8_1 |
0.318 |
|
1976 |
Ling N, Burgus R, Guillemin R. Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity. Proceedings of the National Academy of Sciences of the United States of America. 73: 3942-6. PMID 1069261 DOI: 10.1073/Pnas.73.11.3942 |
0.338 |
|
1976 |
Ling N, Guillemin R. Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs. Proceedings of the National Academy of Sciences of the United States of America. 73: 3308-10. PMID 1067621 DOI: 10.1073/Pnas.73.9.3308 |
0.31 |
|
1976 |
Lazarus LH, Ling N, Guillemin R. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proceedings of the National Academy of Sciences of the United States of America. 73: 2156-9. PMID 1064883 DOI: 10.1073/Pnas.73.6.2156 |
0.343 |
|
1976 |
Orci L, Baetens O, Rufener C, Brown M, Vale W, Guillemin R. Evidence for immunoreactive neurotensin in dog intestinal mucosa. Life Sciences. 19: 559-61. PMID 785139 DOI: 10.1016/0024-3205(76)90236-8 |
0.447 |
|
1976 |
Guillemin R, Gerich JE. Somatostatin: physiological and clinical significance. Annual Review of Medicine. 27: 379-88. PMID 779605 DOI: 10.1146/annurev.me.27.020176.002115 |
0.432 |
|
1976 |
Guillemin R. Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology. 99: 1653-4. PMID 187417 DOI: 10.1210/endo-99-6-1653 |
0.33 |
|
1976 |
Bloom F, Segal D, Ling N, Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science (New York, N.Y.). 194: 630-2. PMID 185694 DOI: 10.1126/Science.185694 |
0.533 |
|
1976 |
Guillemin R. The expanding significance of hypothalamic peptides, or, is endocrinology a branch of neuroendocrinology? Recent Progress in Hormone Research. 33: 1-28. PMID 20649 DOI: 10.1016/B978-0-12-571133-3.50008-8 |
0.34 |
|
1975 |
Vale W, Brazeau P, Rivier C, Brown M, Boss B, Rivier J, Burgus R, Ling N, Guillemin R. Somatostatin. Recent Progress in Hormone Research. 31: 365-97. PMID 1105719 |
0.542 |
|
1975 |
Rivier J, Brazeau P, Vale W, Guillemin R. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. Journal of Medicinal Chemistry. 18: 123-6. PMID 1091734 DOI: 10.1002/Chin.197524427 |
0.429 |
|
1975 |
Brown M, Rivier J, Vale W, Guillemin R. Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs. Biochemical and Biophysical Research Communications. 65: 752-6. PMID 807218 DOI: 10.1016/S0006-291X(75)80209-9 |
0.53 |
|
1974 |
Brazeau P, Rivier J, Vale W, Guillemin R. Inhibition of growth hormone secretion in the rat by synthetic somatostatin. Endocrinology. 94: 184-7. PMID 4808882 DOI: 10.1210/endo-94-1-184 |
0.504 |
|
1974 |
Brazeau P, Vale W, Burgus R, Guillemin R. Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. Canadian Journal of Biochemistry. 52: 1067-72. PMID 4609582 |
0.458 |
|
1974 |
Brazeau P, Vale W, Rivier J, Guillemin R. Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion. Biochemical and Biophysical Research Communications. 60: 1202-7. PMID 4607622 DOI: 10.1016/0006-291X(74)90326-X |
0.457 |
|
1974 |
Brazeau P, Vale W, Rivier J, Guillemin R. Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone. Life Sciences. 15: 351-7. PMID 4549923 DOI: 10.1016/0024-3205(74)90225-2 |
0.49 |
|
1974 |
Gerich JE, Lorenzi M, Schneider V, Kwan CW, Karam JH, Guillemin R, Forsham PH. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Diabetes. 23: 876-80. PMID 4430415 DOI: 10.2337/Diab.23.11.876 |
0.313 |
|
1974 |
Vale W, Rivier C, Brazeau P, Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology. 95: 968-77. PMID 4213073 DOI: 10.1210/endo-95-4-968 |
0.658 |
|
1974 |
Siler TM, Yen SC, Vale W, Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. The Journal of Clinical Endocrinology and Metabolism. 38: 742-5. PMID 4207367 DOI: 10.1210/jcem-38-5-742 |
0.456 |
|
1974 |
Brazeau P, Guillemin R. Editorial: Somatostatin: newcomer from the hypothalamus. The New England Journal of Medicine. 290: 963-964. PMID 4206096 DOI: 10.1056/Nejm197404252901711 |
0.38 |
|
1974 |
Guillemin R. The hormones of the hypothalamus. Progress in Brain Research. 41: 117-32. PMID 4155518 DOI: 10.1016/S0079-6123(08)61903-2 |
0.382 |
|
1973 |
Siler TM, VandenBerg G, Yen SS, Brazeau P, Vale W, Guillemin R. Inhibition of growth hormone release in humans by somatostatin. The Journal of Clinical Endocrinology and Metabolism. 37: 632-4. PMID 4742541 DOI: 10.1210/jcem-37-4-632 |
0.529 |
|
1973 |
Blackwell R, Vale W, Rivier C, Guillemin R. Effect of perphenazine on the secretion of prolactin in vivo and in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 142: 68-71. PMID 4683266 DOI: 10.3181/00379727-142-36960 |
0.634 |
|
1973 |
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (New York, N.Y.). 179: 77-9. PMID 4682131 DOI: 10.1126/Science.179.4068.77 |
0.544 |
|
1973 |
Ling N, Rivier J, Burgus R, Guillemin R. Direct sequence determination of ovine luteinizing hormone releasing factor by mass spectrometry. Biochemistry. 12: 5305-10. PMID 4586516 DOI: 10.1021/Bi00750A013 |
0.378 |
|
1973 |
Guillemin R, Amoss M, Blackwell R, Burgus R, Grant G, Ling N, Monahan M, Rivier J, Vale W. Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors. Journal of Reproduction and Fertility. Supplement. 18: 23-30. PMID 4580254 |
0.494 |
|
1973 |
Rivier J, Vale W, Burgus R, Ling N, Amoss M, Blackwell R, Guillemin R. Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus. Journal of Medicinal Chemistry. 16: 545-9. PMID 4577979 DOI: 10.1021/Jm00263A031 |
0.462 |
|
1973 |
Blackwell R, Vale W, Amoss M, Burgus R, Monahan M, Rivier J, Ling N, Guillemin R. Lack of effect of native or synthetic LRF on secretion of prolactin in vitro. The American Journal of Physiology. 224: 176-9. PMID 4566850 |
0.421 |
|
1973 |
Blackwell R, Amoss M, Vale W, Burgus R, Rivier J, Monahan M, Ling N, Guillemin R. Concomitant release of FSH and LH induced by native and synthetic LRF. The American Journal of Physiology. 224: 170-5. PMID 4566849 |
0.462 |
|
1973 |
Burgus R, Ling N, Butcher M, Guillemin R. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proceedings of the National Academy of Sciences of the United States of America. 70: 684-8. PMID 4514982 DOI: 10.1073/Pnas.70.3.684 |
0.425 |
|
1973 |
Guillemin R, Vale W, Grant G. Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF. Voprosy Biokhimii Mozga. 8: 141-76. PMID 4375346 |
0.423 |
|
1973 |
Vale W, Grant G, Guillemin R. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships. Frontiers in Neuroendocrinology. 375-413. PMID 4369859 |
0.423 |
|
1973 |
Vale W, Blackwell R, Grant G, Guillemin R. TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. Endocrinology. 93: 26-33. PMID 4351315 DOI: 10.1210/endo-93-1-26 |
0.517 |
|
1973 |
Blackwell RE, Guillemin R. Hypothalamic control of adenohypophysial secretions. Annual Review of Physiology. 35: 357-90. PMID 4350616 DOI: 10.1146/annurev.ph.35.030173.002041 |
0.335 |
|
1973 |
Rivier C, Vale W, Guillemin R. An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 142: 842-5. PMID 4348096 DOI: 10.3181/00379727-142-37129 |
0.624 |
|
1973 |
Burgus R, Vale W, Rivier J, Monahan M, Ling N, Grant G, Amoss M, Guillemin R. Chemistry of hypothalamic releasing factors. Progress in Brain Research. 39: 41-51. PMID 4208048 DOI: 10.1016/S0079-6123(08)64065-0 |
0.57 |
|
1973 |
Grant G, Vale W, Guillemin R. Characteristics of the pituitary binding sites for thyrotropin releasing factor. Endocrinology. 92: 1629-33. PMID 4196427 DOI: 10.1210/endo-92-6-1629 |
0.413 |
|
1973 |
Guillemin R. Hypothalamic Hormones: Releasing and Inhibiting Factors Hospital Practice. 8: 111-120. DOI: 10.1080/21548331.1973.11706765 |
0.427 |
|
1972 |
Vale W, Grant G, Amoss M, Blackwell R, Guillemin R. Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology. 91: 562-72. PMID 4630101 DOI: 10.1210/endo-91-2-562 |
0.488 |
|
1972 |
Grant G, Vale W, Guillemin R. Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells. Biochemical and Biophysical Research Communications. 46: 28-34. PMID 4621353 DOI: 10.1016/0006-291X(72)90625-0 |
0.472 |
|
1972 |
Guillemin R. Physiology and chemistry of the hypothalamic releasing factors for gonadotropins: a new approach to fertility control. Contraception. 5: 1-19. PMID 4568272 DOI: 10.1016/0010-7824(72)90076-5 |
0.414 |
|
1972 |
Guillemin R, Amoss M, Blackwell R, Rivier J, Ling N, Vale W. On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide. Biochemical and Biophysical Research Communications. 48: 1093-9. PMID 4560003 DOI: 10.1016/0006-291X(72)90821-2 |
0.54 |
|
1972 |
Monahan MW, Rivier J, Vale W, Guillemin R, Burgus R. (Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF. Biochemical and Biophysical Research Communications. 47: 551-6. PMID 4556826 DOI: 10.1016/0006-291X(72)90914-X |
0.498 |
|
1972 |
Vale W, Grant G, Rivier J, Monahan M, Amoss M, Blackwell R, Burgus R, Guillemin R. Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor. Science (New York, N.Y.). 176: 933-4. PMID 4555980 DOI: 10.1126/science.176.4037.933 |
0.565 |
|
1972 |
Amoss M, Rivier J, Guillemin R. Release of gonadotropins by oral administration of synthetic LRF or a tripeptide fragment of LRF. The Journal of Clinical Endocrinology and Metabolism. 35: 175-7. PMID 4555782 DOI: 10.1210/jcem-35-1-175 |
0.331 |
|
1972 |
Yen SS, Rebar R, Van den Berg G, Naftolin F, Ehara Y, Engblom S, Ryan KJ, Benirschke K, Rivier J, Amoss M, Guillemin R. Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man. The Journal of Clinical Endocrinology and Metabolism. 34: 1108-11. PMID 4553517 DOI: 10.1210/jcem-34-6-1108 |
0.403 |
|
1972 |
Amoss M, Blackwell R, Guillemin R. Stimulation of ovulation in the rabbit triggered by synthetic LRF. The Journal of Clinical Endocrinology and Metabolism. 34: 434-6. PMID 4551071 DOI: 10.1210/jcem-34-2-434 |
0.309 |
|
1972 |
Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proceedings of the National Academy of Sciences of the United States of America. 69: 278-82. PMID 4550508 DOI: 10.1073/PNAS.69.1.278 |
0.532 |
|
1972 |
Vale W, Brazeau P, Grant G, Nussey A, Burgus R, Rivier J, Ling N, Guillemin R. [Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. Comptes Rendus Hebdomadaires Des SéAnces De L'AcadéMie Des Sciences. SéRie D: Sciences Naturelles. 275: 2913-6. PMID 4347575 |
0.443 |
|
1972 |
Guillemin R, Burgus R. The hormones of the hypothalamus. Scientific American. 227: 24-33. PMID 4145789 DOI: 10.1038/Scientificamerican1172-24 |
0.441 |
|
1972 |
RIVIER J, MONAHAN M, VALE W, GRANT G, AMOSS M, BLACKWELL R, GUILLEMIN R, BURGUS R. ChemInform Abstract: FESTPHASEN-PEPTID-SYNTH. AN EINEM BENZHYDRYLAMIN-HARZ VON LRF (RELEASING-FAKTOR DES LUTEINISIERENDEN HORMONS) UND VON ANALOGEN EINSCHLIESSLICH ANTAGONISTEN Chemischer Informationsdienst. 3. DOI: 10.1002/chin.197238383 |
0.301 |
|
1971 |
Vale WW, Burgus R, Dunn TF, Guillemin R. In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. Hormones. 2: 193-203. PMID 5006796 DOI: 10.1159/000178234 |
0.451 |
|
1971 |
Guillemin R, Burgus R, Vale W. The hypothalamic hypophysiotropic thyrotropin-releasing factor. Vitamins and Hormones. 29: 1-39. PMID 5002592 DOI: 10.1016/S0083-6729(08)60046-1 |
0.505 |
|
1971 |
Porter JC, Vale W, Burgus R, Mical RS, Guillemin R. Release of TSH by TRF infused directly into a pituitary stalk portal vessel. Endocrinology. 89: 1054-6. PMID 4999143 DOI: 10.1210/endo-89-4-1054 |
0.487 |
|
1971 |
Guillemin R, Amoss M, Blackwell R, Burgus R, Grant G, Ling N, Monahan M, Rivier J, Vale W. Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor. Gynecologic Investigation. 2: 2-12. PMID 4949825 |
0.328 |
|
1971 |
Amoss M, Burgus R, Blackwell R, Vale W, Fellows R, Guillemin R. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. Biochemical and Biophysical Research Communications. 44: 205-10. PMID 4940370 DOI: 10.1016/S0006-291X(71)80179-1 |
0.435 |
|
1971 |
Guillemin R. Hypothalamic control of the secretion of adenohypophysial hormones. Advances in Metabolic Disorders. 5: 1-51. PMID 4326823 DOI: 10.1016/B978-0-12-027305-8.50021-7 |
0.389 |
|
1971 |
Desiderio DM, Burgus R, Dunn TF, Vale W, Guillemin R, Ward DN. The elucidation of the primary structure of the hypothalamic thyroid stimulating hormone releasing factor of ovine origin by means of mass spectrometry Organic Mass Spectrometry. 5: 221-228. DOI: 10.1002/oms.1210050212 |
0.507 |
|
1970 |
Fleischer N, Burgus R, Vale W, Dunn T, Guillemin R. Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. The Journal of Clinical Endocrinology and Metabolism. 31: 109-12. PMID 4987499 DOI: 10.1210/jcem-31-1-109 |
0.478 |
|
1970 |
Vale W, Burgus R, Dunn TF, Guillemin R. Release of TSH by oral administration of synthetic peptide derivatives with TRF activity. The Journal of Clinical Endocrinology and Metabolism. 30: 148-50. PMID 4984011 DOI: 10.1210/jcem-30-1-148 |
0.449 |
|
1970 |
Burgus R, Dunn TF, Desiderio DM, Ward DN, Vale W, Guillemin R, Felix AM, Gillessen D, Studer RO. Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. Endocrinology. 86: 573-82. PMID 4983136 DOI: 10.1210/endo-86-3-573 |
0.434 |
|
1970 |
Burgus R, Guillemin R. Hypothalamic releasing factors. Annual Review of Biochemistry. 39: 499-526. PMID 4320674 DOI: 10.1146/annurev.bi.39.070170.002435 |
0.394 |
|
1969 |
Amoss MS, Guillemin R. Elevation of plasma LH concentrations induced by LH-releasing factor as measured by radioimmunoassay in the sheep. Endocrinology. 84: 1517-20. PMID 4889115 DOI: 10.1210/endo-84-6-1517 |
0.382 |
|
1969 |
Rodger NW, Beck JC, Burgus R, Guillemin R. Variability of response in the bioassay for a hypothalamic somatotrophin releasing factor based on rat pituitary growth hormone content. Endocrinology. 84: 1373-83. PMID 4889113 DOI: 10.1210/endo-84-6-1373 |
0.397 |
|
1968 |
Vale W, Burgus R, Guillemin R. On the Mechanism of Action of TRF: Effects of Cycloheximide and Actinomycin on the Release of TSH Stimulated in Vitro by TRF and its Inhibition by Thyroxine Neuroendocrinology. 3: 34-46. DOI: 10.1159/000121692 |
0.498 |
|
1967 |
Vale W, Burgus R, Guillemin R. Competition between thyroxine and TRF at the pituitary level in the release of TSH. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 125: 210-3. PMID 6028912 DOI: 10.3181/00379727-125-32051 |
0.452 |
|
1967 |
Davis TQ, Vale W, Guillemin R. Effects of Purified Thyrotropin Releasing Factor (TRF) on Thyrotropin (TSH) Release and Pituitary Acid Phosphatase Activity Neuroendocrinology. 2: 330-341. DOI: 10.1159/000121563 |
0.535 |
|
1967 |
Kastin AJ, Schally AV, Viosca S, Barrett L, Redding TW, D’Angelo SA, Hughes JS, Arai Y, Hiroi M, Mitra J, Gorski RA, Corbin A, Daniels EL, Davis TQ, Vale W, ... Guillemin R, et al. Contents, Vol. 2, 1967 Neuroendocrinology. 2. DOI: 10.1159/000121555 |
0.631 |
|
1966 |
Guillemin R, Ward DN, Sakiz E. Filtration chromatography on substituted Sephadex in the purification of the hypothalamic hormone TRF (TSH-releasing factor). Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 120: 256-8. PMID 5852723 DOI: 10.3181/00379727-120-30502 |
0.322 |
|
1964 |
SCHALLY AV, GUILLEMIN R. SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER. The Journal of Biological Chemistry. 239: 1038-41. PMID 14165903 |
0.372 |
|
1963 |
GUILLEMIN R, SCHALLY AV. CONCENTRATION OF CORTICOTROPIN RELEASING FACTOR (CRF) IN ACID EXTRACTS OF SHEEP HYPOTHALAMUS BY GEL FILTRATION AND COUNTER CURRENT DISTRIBUTION. Texas Reports On Biology and Medicine. 21: 541-5. PMID 14087155 |
0.491 |
|
1963 |
SCHALLY AV, GUILLEMIN R. Isolation and chemical characterization of a beta-CRF from pig posterior pituitary glands. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 112: 1014-7. PMID 13976659 |
0.488 |
|
1962 |
SCHALLY AV, LIPSCOMB HS, LONG JM, DEAR WE, GUILLEMIN R. Chromatography and hormonal activities of dog hypothalamus. Endocrinology. 70: 478-80. PMID 14498007 DOI: 10.1210/endo-70-4-478 |
0.487 |
|
1962 |
SCHALLY AV, LIPSCOMB HS, GUILLEMIN R. Isolation and amino acid sequence of alpha2-corticotropin-releasing factor (alpha2-CRF) from hog pituitary glands. Endocrinology. 71: 164-73. PMID 14498006 DOI: 10.1210/endo-71-1-164 |
0.47 |
|
1962 |
SCHALLY AV, ROBINSON S, GUILLEMIN R. Quantitative aspects of percolation for the extraction of oxytocin and vasopressin. Texas Reports On Biology and Medicine. 20: 680-2. PMID 13976658 |
0.403 |
|
1962 |
GUILLEMIN R, SCHALLY AV, LIPSCOMB HS, ANDERSEN RN, LONG JM. On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin. Endocrinology. 70: 471-7. PMID 13902822 DOI: 10.1210/endo-70-4-471 |
0.542 |
|
1961 |
GUILLEMIN R, SCHALLY AV. On the nature of the hypothalamic substance which controls the secretion of ACTH. Acta Neurovegetativa. 23: 58-62. PMID 13902823 |
0.473 |
|
1960 |
SCHALLY AV, GUILLEMIN R. Studies on corticotropin releasing factor: ion exchange chromotography of pituitary preparations. Texas Reports On Biology and Medicine. 18: 133-46. PMID 14442406 |
0.49 |
|
1960 |
SCHALLY AV, ANDERSEN RN, LONG JM, GUILLEMIN R. Isolation of alpha- and beta-melanocyte stimulating hormones (MSH) on a preparative scale. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 104: 290-3. PMID 14442404 DOI: 10.3181/00379727-104-25812 |
0.475 |
|
1960 |
SCHALLY AV, ANDERSEN RN, LIPSCOMB HS, LONG JM, GUILLEMIN R. Evidence for the existence of two corticotrophin-releasing factors, alpha and beta. Nature. 188: 192-3. PMID 13747238 |
0.491 |
|
1960 |
Schally AV, Andersen RN, Lipscomb HS, Long JM, Guillemin R. Evidence for the existence of two corticotrophin-releasing factors, α and ß Nature. 188: 1192-1193. DOI: 10.1038/1881192a0 |
0.339 |
|
1959 |
GUILLEMIN R, SCHALLY AV. Re-evaluation of a technique of pituitary incubation in vitro as an assay for corticotropin releasing factor. Endocrinology. 65: 555-62. PMID 13830170 DOI: 10.1210/endo-65-4-555 |
0.506 |
|
1959 |
SCHALLY AV, GUILLEMIN R. Concentration of corticotropin releasing factor by chromatography on carboxymethylcellulose. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 100: 138-9. PMID 13634063 |
0.503 |
|
1959 |
SCHALLY AV, LIPSCOMB HS, GUILLEMIN R. Chromatographic separation of oxytocin and vasopressin on carboxymethylcellulose. Biochimica Et Biophysica Acta. 31: 252-4. PMID 13628630 |
0.423 |
|
1953 |
HORAVA A, GUILLEMIN R, SELYE H. [Effect of Reichstein's compound L on certain effects from the administration of an anterior pituitary lobe extract]. Annales D'Endocrinologie. 14: 779-83. PMID 13138984 |
0.352 |
|
1952 |
GUILLEMIN R, SELYE H. [Nephrosclerotic and prophlogistic effect of various preparations of somatotropic hormones]. Annales D'Endocrinologie. 13: 836-40. PMID 13031204 |
0.444 |
|
Show low-probability matches. |